You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ER (estrogen receptor positive)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Feb 1, 2023

Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

Recruiting
  • Hormone Receptor Positive HER-2 Negative Breast Cancer
  • Shanghai, Shanghai, China
    Breast cancer institute of Fudan University Cancer Hospital
Jun 12, 2023

Breast Cancer Trial in Sarasota, Nashville (AC699)

Recruiting
  • Breast Cancer
  • Sarasota, Florida
  • +1 more
Jan 3, 2023

Breast Cancer Stage IV Trial in Irvine (Gallium-68)

Recruiting
  • Breast Cancer Stage IV
  • Irvine, California
    Hoag Memorial Hospital Presbyterian
May 26, 2023

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Assessed by 18F-FES PET/CT in MBC With ER-positive Primary Tumor

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Biyun Wang, MD
    Apr 5, 2023

    Breast Cancer, Breast Cancer, Early-Onset Trial (Giredestrant, Tamoxifen)

    Not yet recruiting
    • Breast Cancer
    • Breast Cancer, Early-Onset
    • (no location specified)
    Jan 18, 2023

    Advanced ER+, HER2-Negative Breast Cancer Trial in Waltham (Elacestrant)

    Completed
    • Advanced ER+, HER2-Negative Breast Cancer
    • Waltham, Massachusetts
      Radius Pharmaceuticals, Inc.
    Aug 16, 2022

    Advanced or Metastatic Breast Cancer Trial in Nashville (AND019 PO QD)

    Not yet recruiting
    • Advanced or Metastatic Breast Cancer
    • AND019 PO QD
    • Nashville, Tennessee
      Sarah Cannon Research Institute
    Jul 19, 2022

    Breast Cancer Trial in Denver, Sarasota, Nashville (AC682)

    Recruiting
    • Breast Cancer
    • Denver, Colorado
    • +4 more
    Dec 12, 2022

    Breast Cancer Trial ([68Ga]Ga-NeoB, [177Lu]Lu-NeoB, Ribociclib)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    May 22, 2023

    Electronic Medical Record-Based Nudge to Reduce SLNB

    Recruiting
    • Breast Cancer
    • Estrogen-receptor-positive Breast Cancer
    • Column-based nudge in the EHR
    • No column-based nudge in the EHR
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Aug 17, 2023

    Estrogen-receptor-positive Breast Cancer, HER2/Neu-Negative Breast Cancer, Advanced Breast Cancerv Trial in Chicago

    Not yet recruiting
    • Estrogen-receptor-positive Breast Cancer
    • +3 more
    • elacestrant, palbociclib, abemaciclib, ribociclib
    • Chicago, Illinois
      Northwestern University
    Sep 25, 2023

    Anatomic Stage IV Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8 Trial in San Francisco (Pembrolizumab,

    Recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • Prognostic Stage IV Breast Cancer AJCC v8
    • Pembrolizumab
    • +2 more
    • San Francisco, California
      University of California, San Francisco
    Jan 5, 2023

    Estrogen Receptor Positive Breast Cancer, Breast Tumor, Metastatic Breast Cancer Trial in Philadelphia ([18F]FES)

    Active, not recruiting
    • Estrogen Receptor Positive Breast Cancer
    • +2 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania Hospital
    Jul 5, 2022

    Estrogen Receptor-positive Breast Cancer Trial in Nashville (2-Week Ketogenic Diet, Letrozole)

    Recruiting
    • Estrogen Receptor-positive Breast Cancer
    • Nashville, Tennessee
      Vanderbilt-Ingram Cancer Center
    Sep 20, 2022

    Breast Cancer Trial in Washington, Baltimore (Outcomes4Me, Semi-structured interview)

    Recruiting
    • Breast Cancer
    • Outcomes4Me
    • Semi-structured interview
    • Washington, District of Columbia
    • +1 more
    Jan 13, 2023

    Breast Tumors, Invasive Breast Cancer, Estrogen-receptor-positive Breast Cancer Trial in United States (Z-endoxifen, exemestane,

    Recruiting
    • Breast Neoplasms
    • +3 more
    • Phoenix, Arizona
    • +3 more
    Jan 30, 2023

    Breast Cancer, Estrogen Receptor-positive Breast Cancer Trial in Charlottesville (Aspirin, Tamoxifen Pill, Doxorubicin)

    Withdrawn
    • Breast Cancer
    • Estrogen Receptor-positive Breast Cancer
    • Charlottesville, Virginia
      University of Virginia
    Nov 12, 2021

    ER+ Breast Cancer Trial in Sherbrooke (4FMFES-PET)

    Recruiting
    • ER+ Breast Cancer
    • 4FMFES-PET
    • Sherbrooke, Quebec, Canada
      Université deSherbrooke
    Jul 18, 2022

    Breast Tumors Trial in Japan (E7090, Fulvestrant, Exemestane)

    Recruiting
    • Breast Neoplasms
    • Nagoya, Aichi, Japan
    • +10 more
    Nov 11, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

    Recruiting
    • Estrogen Receptor-positive Breast Cancer
    • HER2-positive Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Hospital
    Sep 29, 2021

    Estrogen Receptor Positive Breast Cancer Trial in Houston, Sugar Land (TAK-228, Tamoxifen)

    Completed
    Has Results
    • Estrogen Receptor Positive Breast Cancer
    • Houston, Texas
    • +2 more
    Aug 27, 2021

    Breast Tumors, Breast Cancer, Estrogen-receptor Positive Breast Cancer Trial in France, United Kingdom, United States (H3B-6545)

    Active, not recruiting
    • Breast Neoplasms
    • +7 more
    • Goodyear, Arizona
    • +38 more
    Jun 29, 2022